BioSyent

(OTC) BIOYF

Current Price$10.15

Market Cap$116.12M

Since IPO (2012)+1,882%

5 Year+70%

1 Year+19%

1 Month-7%

BioSyent Financials at a Glance

Market Cap

$116.12M

Revenue (TTM)

CA$46.01M

Net Income (TTM)

CA$9.04M

EPS (TTM)

$0.57

P/E Ratio

17.41

Dividend

$0.15

Beta (Volatility)

0.18 (Low)

Dividend

$0.15

Beta (Volatility)

0.18 (Low)

Price

$10.15

Volume

2,947

Open

$10.20

Price

$10.15

Volume

2,947

Open

$10.20

Previous Close

$10.10

Daily Range

$10.12 - $10.20

52-Week Range

$7.63 - $12.00

Dividend

$0.15

Beta (Volatility)

0.18 (Low)

Price

$10.15

Volume

2,947

Open

$10.20

Previous Close

$10.10

Daily Range

$10.12 - $10.20

52-Week Range

$7.63 - $12.00

BIOYF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioSyent

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

René C. Goehrum

Website

www.biosyent.com

Headquarters

Mississauga, ON L5N 6M1, CA

BIOYF Financials

Key Financial Metrics (TTM)

Gross Margin

74%

Operating Margin

25%

Net Income Margin

20%

Return on Equity

23%

Return on Capital

25%

Return on Assets

14%

Earnings Yield

5.74%

Dividend Yield

1.48%

Payout Ratio

25.54%

Stock Overview

Market Cap

$116.12M

Shares Outstanding

11.50M

Volume

2.95K

Avg. Volume

1.88K

Financials (TTM)

Gross Profit

CA$32.08M

Operating Income

CA$11.30M

EBITDA

CA$12.16M

Operating Cash Flow

CA$9.61M

Capital Expenditure

-CA$54.00K

Free Cash Flow

CA$9.56M

Cash & ST Invst.

CA$28.63M

Total Debt

CA$840.42K

BioSyent Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

CA$13.94M

+27.0%

Gross Profit

CA$9.70M

+16.4%

Gross Margin

69.59%

N/A

Market Cap

$116.12M

N/A

Market Cap/Employee

$1.94M

N/A

Employees

N/A

Net Income

CA$2.35M

+1.3%

EBITDA

CA$3.67M

+8.6%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

CA$5.67M

-65.5%

Accounts Receivable

CA$7.57M

+38.2%

Inventory

CA$11.32M

+114.5%

Long Term Debt

CA$815.30K

+3.4%

Short Term Debt

CA$4.45M

+2102.8%

Return on Assets

14.46%

N/A

Return on Invested Capital

25.13%

N/A

Free Cash Flow

CA$2.93M

+463.7%

Operating Cash Flow

CA$2.96M

+512.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LOVFFCannara Biotech Inc.

LOVFFCannara Biotech Inc.$1.25+0.81%

GRUSFGrown Rogue International Inc.

GRUSFGrown Rogue International Inc.$0.41+2.85%

PLNHPlanet 13 Holdings Inc.

PLNHPlanet 13 Holdings Inc.$0.16+0.32%

ETSTEarth Science Tech, Inc.

ETSTEarth Science Tech, Inc.$0.17+1.69%

IUGNFImugene Limited

IUGNFImugene Limited$0.09-5.49%

SPHRYStarpharma Holdings Limited

SPHRYStarpharma Holdings Limited$4.76-1.35%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CZRCaesars Entertainment

CZRCaesars Entertainment$29.09+0.01%

IUSBiShares Trust - iShares Core Universal Usd Bond ETF

IUSBiShares Trust - iShares Core Universal Usd Bond ETF$46.18+0.00%

ATPCAgape Atp

ATPCAgape Atp$6.46+1.27%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.33-0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.41+0.01%

SIDUSidus Space

SIDUSidus Space$5.20-0.15%

IALTBlackrock ETF Trust - iShares Systematic Alternatives Active ETF

IALTBlackrock ETF Trust - iShares Systematic Alternatives Active ETF$28.26+0.00%

Questions About BIOYF

What is the current price of BioSyent?

BioSyent is trading at $10.15 per share.

What is the 52-week range for BioSyent?

Over the past 52 weeks, BioSyent has traded between $7.63 and $12.00.

How much debt does BioSyent have?

As of the most recent reporting period, BioSyent reported total debt of CA$3.76M.

How much cash does BioSyent have on hand?

BioSyent reported CA$4.40M in cash and cash equivalents in its most recent financial results.

What is BioSyent’s dividend yield?

BioSyent currently has a dividend yield of 1.48%.

BioSyent

BioSyent Financials at a Glance

BIOYF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About BioSyent

BIOYF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

BioSyent Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BIOYF

What is the current price of BioSyent?

What is the 52-week range for BioSyent?

How much debt does BioSyent have?

How much cash does BioSyent have on hand?

What is BioSyent’s dividend yield?

Premium Investing Services